Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04309123 · ClinicalTrials.gov registry record · NA
Pilot Study of TransAeris® System in Surgical Patients at Risk of Prolonged Mechanical Ventilation
A NA study, sponsored by Synapse Biomedical.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT04309123 is a NA study that has completed, run by Synapse Biomedical. The registered enrollment target is 40 participants.
The verdict
NCT04309123, a NA study, has completed, sponsored by Synapse Biomedical.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study will be conducted as a pilot trial of the TransAeris system for the prevention and treatment of ventilator-induced diaphragm dysfunction (VIDD) in patients identified prior to surgery to be at greater risk of prolonged mechanical ventilation (PMV).
Interventions
- DEVICE TransAeris System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-03-30 |
| Est. Completion | 2021-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04309123
The ClinicalTrials.gov registry entry for NCT04309123 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Synapse Biomedical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TransAeris System is the first listed.
NCT04309123 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04309123 about?
NCT04309123 is a clinical study titled "Pilot Study of TransAeris® System in Surgical Patients at Risk of Prolonged Mechanical Ventilation". This study will be conducted as a pilot trial of the TransAeris system for the prevention and treatment of ventilator-induced diaphragm dysfunction (VIDD) in patients identified prior to surgery to be at greater risk of prolonged mechanical ventilation (PMV).
What is the current status of trial NCT04309123?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2020-03-30. Estimated completion is 2021-04-01.
What interventions are being tested in trial NCT04309123?
The interventions under investigation include: TransAeris System (DEVICE).
Who is sponsoring clinical trial NCT04309123?
This trial is sponsored by Synapse Biomedical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.